Matarin Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1.42M Sell
81,550
-35,299
-30% -$563K 0.35% 125
2020
Q3
$1.61M Buy
+116,849
New +$1.72M 0.34% 123
2020
Q2
Sell
-34,258
Closed -$374K 226
2020
Q1
$374K Buy
+34,258
New +$632K 0.06% 189
2017
Q4
Sell
-421,005
Closed -$9.24M 312
2017
Q3
$9.24M Buy
421,005
+30,812
+8% +$696K 0.79% 42
2017
Q2
$9.4M Buy
390,193
+7,496
+2% +$191K 0.87% 25
2017
Q1
$10.7M Buy
382,697
+51,590
+16% +$1.35M 1.05% 13
2016
Q4
$8.09M Buy
331,107
+60,726
+22% +$1.39M 0.91% 23
2016
Q3
$6.81M Buy
+270,381
New +$6.48M 0.75% 42

Other funds holding SBRA

Matarin Capital Management's SBRA Position: Q4 2020 in Review

Matarin Capital Management reduced its Sabra Healthcare REIT (SBRA) stake by 30% in Q4 2020, selling an estimated $563K and leaving 81,550 shares worth $1.42M. The position accounts for 0.35% of the portfolio, ranked #125.

Matarin Capital Management first reported a position in SBRA in Q3 2016 and has held it in 8 quarters since. The position peaked at $10.7M in Q1 2017. 322 funds tracked by Wall St. Rank hold SBRA as of Q4 2020.

  • Matarin Capital Management held 81,550 shares of Sabra Healthcare REIT worth $1.42M as of Q4 2020.
  • Matarin Capital Management sold 35,299 Sabra Healthcare REIT shares in Q4 2020, an estimated $563K.
  • Sabra Healthcare REIT made up 0.35% of Matarin Capital Management's portfolio in Q4 2020, its #125 holding.
  • Matarin Capital Management first reported a position in Sabra Healthcare REIT in Q3 2016 and has held it in 8 quarters since.
  • Matarin Capital Management's Sabra Healthcare REIT position peaked at $10.7M in Q1 2017.
  • 322 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2020.

Based on Matarin Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.